Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Hematology & Oncology|May 26, 2020
Biomarker-driven management strategies for peripheral T cell lymphomaErin Mulvey, Jia Ruan
Blood|February 28, 2025
The Future of Follicular Lymphoma Management: Strategies on the HorizonErin Mulvey, Sarah C Rutherford, John P Leonard
Plos One|November 8, 2016
CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in MiceXuguang Chen, Yunyue Wang, David Nelson, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
STI1 domain dynamically engages transient helices in disordered regions to drive self-association and phase separation of yeast ubiquilin Dsk2Nirbhik Acharya, Emily A Daniel, Thuy P Dao, et al.
Future Oncology (London, England)|October 21, 2025
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the USErin Mulvey, Jason Shafrin, Kyi-Sin Than, et al.
Molecular Cancer Therapeutics|July 6, 2022
Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell LymphomaFlorencia Cayrol, Maria V Revuelta, Mercedes Debernardi, et al.
Blood|August 24, 2021
Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCLPeter Martin, Nancy L Bartlett, Julio C Chavez, et al.
Plos One|July 15, 2015
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk SarcomasXin Huang, Haein Park, Joseph Greene, et al.
Blood|February 16, 2023
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCLJia Ruan, Alison Moskowitz, Neha Mehta-Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell LymphomaEdward R Scheffer Cliff, Guido D Pelaez, Fei Wan, et al.
Pageof 1